State-of-the-art pancreatic MRI

American Journal of Roentgenology

Volumn 195, Issue 1, 2010, Pages 42-53

  Sandrasegaran, Kumaresan ^a   Lin, Chen ^a   Akisik, Fatih M ^a   Tann, Mark ^a  

^a INDIANA UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

MRCP; MRI; Pancreas; Secretin

Indexed keywords

ARTICLE; CHRONIC PANCREATITIS; DIAGNOSTIC IMAGING; FEMALE; HUMAN; IMAGE QUALITY; INTERMETHOD COMPARISON; MAGNETIC RESONANCE CHOLANGIOPANCREATOGRAPHY; MALE; NUCLEAR MAGNETIC RESONANCE IMAGING; PANCREAS; PANCREAS DISEASE; PANCREAS TUMOR; PRIORITY JOURNAL; THREE DIMENSIONAL IMAGING;

CHOLANGIOPANCREATOGRAPHY, MAGNETIC RESONANCE; CONTRAST MEDIA; HUMANS; MAGNETIC RESONANCE IMAGING; PANCREATIC DISEASES; SECRETIN;

EID: 77954736000     PISSN: 0361803X     EISSN: 15463141     Source Type: Journal    
DOI: 10.2214/AJR.10.4421     Document Type: Article

References (62)

1. Coppens E, Metens T, Winant C, Matos C. Pineapple juice labeled with gadolinium: a convenient oral contrast for magnetic resonance cholangiopancreatography. Eur Radiol 2005; 15:2122-2129
2. Papanikolaou N, Karantanas A, Maris T, Gourtsoyiannis N. MR cholangiopancreatography before and after oral blueberry juice administration. J Comput Assist Tomogr 2000; 24:229-234
3. Riordan RD, Khonsari M, Jeffries J, Maskell GF, Cook PG. Pineapple juice as a negative oral contrast agent in magnetic resonance cholangiopancreatography: a preliminary evaluation. Br J Radiol 2004; 77:991-999
4. Frossard JL, Lescuyer P, Pastor CM. Experimental evidence of obesity as a risk factor for severe acute pancreatitis. World J Gastroenterol 2009; 15:5260-5265
5. Mathur A, Pitt HA, Marine M, et al. Fatty pancreas: a factor in postoperative pancreatic fistula. Ann Surg 2007; 246:1058-1064
6. Mathur A, Marine M, Lu D, et al. Nonalcoholic fatty pancreas disease. HPB (Oxford) 2007; 9:312-318
7. Reeder SB, Pineda AR, Wen Z, et al. Iterative decomposition of water and fat with echo asymmetry and least-squares estimation (IDEAL): application with fast spin-echo imaging. Magn Reson Med 2005; 54:636-644
8. Reeder SB, McKenzie CA, Pineda AR, et al. Water- fat separation with IDEAL gradient-echo imaging. J Magn Reson Imaging 2007; 25:644-652
9. Costa DN, Pedrosa I, McKenzie C, Reeder SB, Rofsky NM. Body MRI using IDEAL. AJR 2008; 190:1076-1084
10. Kim H, Taksali SE, Dufour S, et al. Comparative MR study of hepatic fat quantification using single- voxel proton spectroscopy, two-point Dixon and three-point IDEAL. Magn Reson Med 2008; 59:521-527
11. Coenegrachts K, ter Beek L, Haspeslagh M, Bipat S, Stoker J, Rigauts H. Comparison of respiratory-triggered T2-weighted turbo spin-echo imaging versus breath-hold T2-weighted turbo spin-echo imaging: distinguishing benign from malignant liver lesions in patients with colorectal cancer. JBR-BTR 2009; 92:195-201
12. Lee SS, Byun JH, Hong HS, et al. Image quality and focal lesion detection on T2-weighted MR imaging of the liver: comparison of two high-resolution free-breathing imaging techniques with two breath-hold imaging techniques. J Magn Reson Imaging 2007; 26:323-330
13. Ichikawa T, Araki T. Fast magnetic resonance imaging of liver. Eur J Radiol 1999; 29:186-210 (Pubitemid 29268373)
14. Lauenstein TC, Sharma P, Hughes T, Heberlein K, Tudorascu D, Martin DR. Evaluation of optimized inversion-recovery fat-suppression techniques for T2-weighted abdominal MR imaging. J Magn Reson Imaging 2008; 27:1448-1454
15. Reeder SB, Yu H, Johnson JW, et al. T1- and T2-weighted fast spin-echo imaging of the brachial plexus and cervical spine with IDEAL water-fat separation. J Magn Reson Imaging 2006; 24:825-832
16. Low RN, Ma J, Panchal N. Fast spin-echo triple-echo Dixon: initial clinical experience with a novel pulse sequence for fat-suppressed T2-weighted abdominal MR imaging. J Magn Reson Imaging 2009; 30:569-577
17. Ma J, Son JB, Zhou Y, Le-Petross H, Choi H. Fast spin-echo triple-echo Dixon (fTED) technique for efficient T2-weighted water and fat imaging. Magn Reson Med 2007; 58:103-109
18. Bayramoglu S, Kilickesmez O, Cimilli T, et al. T2-weighted MRI of the upper abdomen: comparison of four fat-suppressed T2-weighted sequences including PROPELLER (BLADE) technique. Acad Radiol 2010; 17:368-374
19. Nanko S, Oshima H, Watanabe T, Sasaki S, Hara M, Shibamoto Y. Usefulness of the application of the BLADE technique to reduce motion artifacts on navigation-triggered prospective acquisition correction (PACE) T2-weighted MRI (T2WI) of the liver. J Magn Reson Imaging 2009; 30:321-326
20. Hirokawa Y, Isoda H, Maetani YS, Arizono S, Shimada K, Togashi K. Evaluation of motion correction effect and image quality with the periodically rotated overlapping parallel lines with enhanced reconstruction (PROPELLER) (BLADE) and parallel imaging acquisition technique in the upper abdomen. J Magn Reson Imaging 2008; 28:957-962
21. Michaely HJ, Kramer H, Weckbach S, Dietrich O, Reiser MF, Schoenberg SO. Renal T2-weighted turbo-spin-echo imaging with BLADE at 3.0 Tesla: initial experience. J Magn Reson Imaging 2008; 27:148-153
22. Arizono S, Isoda H, Maetani YS, et al. High-spatial- resolution three-dimensional MR cholangiography using a high-sampling-efficiency technique (SPACE) at 3T: comparison with the conventional constant flip angle sequence in healthy volunteers. J Magn Reson Imaging 2008; 28:685-690
23. Weigel M, Hennig J. Contrast behavior and relaxation effects of conventional and hyperecho-turbo spin echo sequences at 1.5 and 3 T. Magn Reson Med 2006; 55:826-835
24. Morita S, Ueno E, Masukawa A, et al. Comparison of SPACE and 3D TSE MRCP at 1.5T focusing on difference in echo spacing. Magn Reson Med Sci 2009; 8:101-105
25. Haystead CM, Dale BM, Merkle EM. N/2 ghosting artifacts: elimination at 3.0-T MR cholangiography with SPACE pulse sequence. Radiology 2008; 246:589-595
26. Herborn CU, Vogt F, Lauenstein TC, Goyen M, Debatin JF, Ruehm SG. MRI of the liver: can true FISP replace HASTE? J Magn Reson Imaging 2003; 17:190-196
27. Numminen K, Halavaara J, Isoniemi H, et al. Magnetic resonance imaging of the liver: true fast imaging with steady state free precession sequence facilitates rapid and reliable distinction between hepatic hemangiomas and liver malignancies. J Comput Assist Tomogr 2003; 27:571-576
28. Yoon LS, Catalano OA, Fritz S, Ferrone CR, Hahn PF, Sahani DV. Another dimension in magnetic resonance cholangiopancreatography: comparison of 2- and 3-dimensional magnetic resonance cholangiopancreatography for the evaluation of intraductal papillary mucinous neoplasm of the pancreas. J Comput Assist Tomogr 2009; 33:363-368
29. Sodickson A, Mortele KJ, Barish MA, Zou KH, Thibodeau S, Tempany CM. Three-dimensional fast-recovery fast spin-echo MRCP: comparison with two-dimensional single-shot fast spin-echo techniques. Radiology 2006; 238:549-559
30. Busse RF, Riederer SJ, Fletcher JG, Bharucha AE, Brandt KR. Interactive fast spin-echo imaging. Magn Reson Med 2000; 44:339-348
31. Chey WY, Chang TM. Secretin: 100 years later. J Gastroenterol 2003; 38:1025-1035
32. Motosugi U, Ichikawa T, Araki T, et al. Secretin-stimulating MRCP in patients with pancreatobiliary maljunction and occult pancreatobiliary re- flux: direct demonstration of pancreatobiliary reflux. Eur Radiol 2007; 17:2262-2267
33. Czako L. Diagnosis of early-stage chronic pancreatitis by secretin-enhanced magnetic resonance cholangiopancreatography. J Gastroenterol 2007; 42[suppl 17]:113-117
34. Sugiyama M, Haradome H, Atomi Y. Magnetic resonance imaging for diagnosing chronic pancreatitis. J Gastroenterol 2007; 42[suppl 17]:108-112
35. Balci NC, Alkaade S, Magas L, Momtahen AJ, Burton FR. Suspected chronic pancreatitis with normal MRCP: findings on MRI in correlation with secretin MRCP. J Magn Reson Imaging 2008; 27:125-131
36. Sai JK, Suyama M, Kubokawa Y, Watanabe S. Diagnosis of mild chronic pancreatitis (Cambridge classification): comparative study using secretin injection-magnetic resonance cholangiopancreatography and endoscopic retrograde pancreatography. World J Gastroenterol 2008; 14:1218-1221
37. Lee NJ, Kim KW, Kim TK, et al. Secretin-stimulated MRCP. Abdom Imaging 2006; 31:575-581
38. Bali MA, Sztantics A, Metens T, et al. Quantification of pancreatic exocrine function with secretin-enhanced magnetic resonance cholangiopancreatography: normal values and short-term effects of pancreatic duct drainage procedures in chronic pancreatitis: initial results. Eur Radiol 2005; 15:2110-2121
39. Punwani S, Gillams AR, Lees WR. Non-invasive quantification of pancreatic exocrine function using secretin-stimulated MRCP. Eur Radiol 2003; 13:273-276 (Pubitemid 36798603)
40. Czako L, Endes J, Takacs T, Boda K, Lonovics J. Evaluation of pancreatic exocrine function by secretin- enhanced magnetic resonance cholangiopancreatography. Pancreas 2001; 23:323-328
41. Cappeliez O, Delhaye M, Deviere J, et al. Chronic pancreatitis: evaluation of pancreatic exocrine function with MR pancreatography after secretin stimulation. Radiology 2000; 215:358-364
42. Hellund JC, Skattum J, Buanes T, Geitung JT. Secretin-stimulated magnetic resonance cholangiopancreatography of patients with unclear disease in the pancreaticobiliary tract. Acta Radiol 2007; 48:135-141
43. Ragozzino A, Manfredi R, Scaglione M, De Ritis R, Romano S, Rotondo A. The use of MRCP in the detection of pancreatic injuries after blunt trauma. Emerg Radiol 2003; 10:14-18 (Pubitemid 36667546)
44. Sharma P, Kitajima HD, Kalb B, Martin DR. Gadolinium-enhanced imaging of liver tumors and manifestations of hepatitis: pharmacodynamic and technical considerations. Top Magn Reson Imaging 2009; 20:71-78
45. Earls JP, Rofsky NM, Decorato DR, Krinsky GA, Weinreb JC. Hepatic arterial-phase dynamic gadolinium- enhanced MR imaging: optimization with a test examination and a power injector. Radiology 1997; 202:268-273
46. Materne R, Horsmans Y, Jamart J, Smith AM, Gigot JF, Van Beers BE. Gadolinium-enhanced arterial-phase MR imaging of hypervascular liver tumors: comparison between tailored and fixed scanning delays in the same patients. J Magn Reson Imaging 2000; 11:244-249
47. Pruessmann KP. Encoding and reconstruction in parallel MRI. NMR Biomed 2006; 19:288-299
48. Glockner JF, Hu HH, Stanley DW, Angelos L, King K. Parallel MR imaging: a user's guide. RadioGraphics 2005; 25:1279-1297
49. Hussain SM, Wielopolski PA, Martin DR. Abdominal magnetic resonance imaging at 3.0 T: problem or a promise for the future? Top Magn Reson Imaging 2005; 16:325-335
50. Akisik FM, Sandrasegaran K, Aisen AM, Lin C, Lall C. Abdominal MR imaging at 3.0 T. Radio-Graphics 2007; 27:1433-1444
51. Bammer R, Schoenberg SO. Current concepts and advances in clinical parallel magnetic resonance imaging. Top Magn Reson Imaging 2004; 15:129-158
52. Onishi H, Kim T, Hori M, et al. MR cholangiopancreatography at 3.0 T: intraindividual comparative study with MR cholangiopancreatography at 1.5 T for clinical patients. Invest Radiol 2009; 44:559-565
53. Schmidt GP, Wintersperger B, Graser A, Baur- Melnyk A, Reiser MF, Schoenberg SO. High-resolution whole-body magnetic resonance imaging applications at 1.5 and 3 tesla: a comparative study. Invest Radiol 2007; 42:449-459
54. Kim SY, Byun JH, Lee SS, Park SH, Jang YJ, Lee MG. Biliary tract depiction in living potential liver donors: intraindividual comparison of MR cholangiography at 3.0 and 1.5 T. Radiology 2010; 254:469-478
55. Koelblinger C, Schima W, Weber M, et al. Gadoxate- enhanced T1-weighted MR cholangiography: comparison of 1.5 T and 3.0 T. Rofo 2009; 181:587-592
56. Ramalho M, Heredia V, Tsurusaki M, Altun E, Semelka RC. Quantitative and qualitative comparison of 1.5 and 3.0 tesla MRI in patients with chronic liver diseases. J Magn Reson Imaging 2009; 29:869-879
57. Isoda H, Kataoka M, Maetani Y, et al. MRCP imaging at 3.0 T vs. 1.5 T: preliminary experience in healthy volunteers. J Magn Reson Imaging 2007; 25:1000-1006
58. von Falkenhausen MM, Lutterbey G, Morakkabati- Spitz N, et al. High-field-strength MR imaging of the liver at 3.0 T: intraindividual comparative study with MR imaging at 1.5 T. Radiology 2006; 241:156-166
59. Edelman RR, Salanitri G, Brand R, et al. Magnetic resonance imaging of the pancreas at 3.0 tesla: qualitative and quantitative comparison with 1.5 tesla. Invest Radiol 2006; 41:175-180
60. Goncalves Neto JA, Altun E, Elazzazi M, Vaidean GD, Chaney M, Semelka RC. Enhancement of abdominal organs on hepatic arterial phase: quantitative comparison between 1.5- and 3.0-T magnetic resonance imaging. Magn Reson Imaging 2010; 28:47-55
61. Lee VS, Hecht EM, Taouli B, Chen Q, Prince K, Oesingmann N. Body and cardiovascular MR imaging at 3.0 T. Radiology 2007; 244:692-705
62. Asbach P, Klessen C, Kroencke TJ, et al. Magnetic resonance cholangiopancreatography using a free-breathing T2-weighted turbo spin-echo sequence with navigator-triggered prospective acquisition correction. Magn Reson Imaging 2005; 23:939-945 (Pubitemid 41681674)